ECOG PCO-RL: E1508: A Randomized Phase II Study of Cisplatin and Etoposide in Combination with Either Hedgehop Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients with Extensive Stage Small Cell Lung Cancer

Project: Research project

Project Details

Effective start/end date6/1/095/31/12


  • Frontier Science and Technology Research Foundation (PCOE1508R-00 // CA021115)
  • National Cancer Institute (PCOE1508R-00 // CA021115)